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Abstract
Background
After cerebral injury blood-brain barrier disruption significantly impairs brain homeostasis.
Volatile anesthetics have been shown to be protective in ischemia-reperfusion injury scenar-
ios. Their impact on brain endothelial cells after hypoxia-reoxygenation (H/R) has not yet
been studied in detail.
Methods
Rat brain endothelial cells (RBE4) were exposed to severe hypoxia and reoxygenated in air
in the presence or absence of sevoflurane. Changes in dextran permeability and architec-
ture of the cellular junctional proteins ZO-1 and β-catenin were measured. To determine
necrosis and apoptosis rate DNA content, LDH release and caspase activity were quanti-
fied. The role of vascular endothelial growth factor (VEGF) as an inflammatory mediator
increasing vascular permeability was assessed. At the same time, it was evaluated if sevo-
flurane effects are mediated through VEGF. Results were analyzed by unpaired t-tests or
one way-analysis of variance followed by Bonferroni’s correction.
Results
H/R led to a 172% increase in permeability (p<0.001), cell swelling and qualitatively but not
quantitatively modified expression of ZO-1, β-catenin and F-actin. In the presence of sevo-
flurane during reoxygenation, barrier function improved by 96% (p = 0.042) in parallel to a
decrease of the cell size and less re-arranged junction proteins and F-actin. Sevoflurane-
induced improvement of the barrier function could not be explained on the level of necrosis
or apoptosis as they remained unchanged independent of the presence or absence of the
volatile anesthetic. Increased expression of VEGF after H/R was attenuated by sevoflurane
by 34% (p = 0.004). Barrier protection provided by sevoflurane was similar to the application
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of a blocking VEGF-antibody. Furthermore, the protective effect of sevoflurane was abol-
ished in the presence of recombinant VEGF.
Conclusions
In H/R-induced rat brain endothelial cell injury sevoflurane maintains endothelial barrier
function through downregulation of VEGF, which is a key player not only in mediating injury,
but also with regard to the protective effect of sevoflurane.
Introduction
The blood-brain barrier (BBB) strictly controls and regulates molecular exchange between the
cerebral and vascular compartments, thereby safeguarding cerebral function [1]. Large protein
complexes of endothelial cells, which form tight and adherens junctions, limit the paracellular
flux [2]. The tight junction protein zonula occludens (ZO-1) and the adherens junction protein
β-catenin are thereby key components contributing to normal barrier function [3]. Experi-
mental models suggest that the generation of brain edema after BBB breakdown involves an
early phase of leakage after 4 hours [4]. Particularly in brain injury, this early phase of brain
edema formation involves an increase of vascular endothelial growth factor (VEGF) [5], one of
the most potent permeability factors [6] [7]. VEGF directly modifies endothelial cell junctions
[8, 9] [10] as well as the actin cytoskeleton [11] and may therefore promote further disruption
of the blood-brain barrier, finally leading to neuronal malfunction [12].
Volatile anesthetics such as sevoflurane have been shown to sustain tissue integrity after ische-
mia-reperfusion (hypoxia-reoxygenation, H/R) injury in the heart [13], the liver [14], the lung
[15] and the kidney [16]. They also affect the BBB and its function, with some authors postulat-
ing neuroprotective effects of volatile anesthetics [17, 18]. So far, limited information is available
regarding the interaction of these anesthetics with the endothelial component of the BBB.
Working from the hypothesis that sevoflurane improves H/R-induced endothelial barrier
dysfunction, we investigated whether the application of sevoflurane alters the permeability of
rat brain endothelial cell (RBE4) layers and modifies important tight and adherens junctions.
VEGF as one of the key permeability factors was determined in order to gain more insight into
the possible signaling pathway.
Methods
Cell culture
RBE4 rat brain endothelial cells (P. Couraud, Cochin Institute, University Descartes, Paris)
were grown on collagen-coated plates (rat tail collagen, 30–100μg (cm2)-1 Sigma-Aldrich Che-
mie GmbH, Buchs, Switzerland) [19]. Media contained F10 and α-MEM in equal amounts,
enriched with 10% fetal bovine serum (Life technologies, Zug, Switzerland), 2% 4-2- hydro-
xyethyl-1 piperazinethanesulfonic acid (Hepes) 1M (Sigma), 1ng/ml human basic fibroblast
growth factor (PreproTech, London, UK) and 300μg ml-1 geneticin (Sigma). Cells were incu-
bated in humidified room air (humidity 70–90%) enriched with 5% CO2.
Hypoxia and reoxygenation injury with or without sevoflurane
For all experiments, cells were seeded at a density of 50,000 cells ml-1 and grown for 2–3 days
to a confluency of 80–100%. Experiments started with either severe hypoxic (0.2% oxygen) or
Sevoflurane postconditioning of injured brain endothelial cells
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normoxic (21% oxygen) treatment for 24 hours. For hypoxic exposure, cells were transferred
to an anaerobic work station (Concept 400M, Ruskinn Technology, Baker Company, Sanford,
Maine USA), while control cells remained in the normal incubator. Reoxygenation with sevo-
flurane was performed in Oxoid chambers (Oxoid, Hampshire, UK) for 4 hours in a mixture
of room air enriched with 2.2% sevoflurane (Baxter Schweiz AG, Volketswil, Switzerland) and
5% CO2, defined as postconditioning, in line with previous work carried out by our group
[20].
Permeability assays
For permeability analysis, RBE4 cells were grown on collagen-coated TranswellTM chambers
with 6.5mm-diameter polycarbonate inlays of pore size 0.4μm (Corning Incorporated, Corn-
ing, NY, USA). After exposure to H/R (or normoxia as control), medium was removed from
the top compartment and fluorescein isothiocyanate (FITC)-dextran with a molecular weight
of 40kD (Sigma) was added at a concentration of 1mg ml-1. FITC-dextran permeation to the
lower compartment was measured after 10, 20 and 30 minutes for the clearance curve analysis
and after 30 minutes for determination of permeability. The amount of FITC permeation was
quantified with the aid of a fluorometer (Infinite 200 pro, Tecan, Ma¨nnedorf, Switzerland) at
an excitation wave length of 490nm and an emission wave length of 525nm. The cleared vol-
ume was plotted against time and the permeability coefficient Pe was calculated according to
Rist et al. [21]: 1/PS = 1/me-1/mf and Pe = PS/S, where PS is defined as permeability surface
area product, and S as surface area of the filter (0.331cm2). me and mf represent the slopes of
the clearance curves of filters with (me) and filters without endothelial cells (mf) in ml = (cm3)
min-1.
Protein extraction
Cells were washed with ice-cold, phosphate-buffered saline (PBS, Kantonsapotheke Zurich,
Switzerland; S1 Table) and homogenized in protein lysis buffer (containing 250mM Sucrose,
20mM Hepes, 10mM KCl, 1.5mM MgCl2, 1mM EDTA, 1mM EGTA, 1mM DTT). 100μl of
protease inhibitor mix (8340) and 50μl phosphatase inhibitor (P5726 and P0004), all pur-
chased form Sigma, were added per 5x106 cells. Protein concentrations were determined with
the aid of a colorimetric assay based on the Bradford-dye binding method (Biorad Laborato-
ries AG, Cressier, Switzerland), according to manufacturer’s instructions.
Immunoblots
For ZO-1 and β-catenin quantification, proteins were denatured with sodium-dodecyl sulfate
(SDS) and then loaded onto a polyacrylamide gel. After separation via electrophoresis, proteins
were transferred to nitrocellulose membranes (material provided by Biorad and Sigma). Mem-
branes were then blocked in 5% non-fat dry milk in tris-buffered saline (TBS; S1 Table).
Primary antibodies were incubated at 4˚C overnight with gentle shaking. Membranes were
washed with TBS and 0.1% Tween 20 (Sigma) and consecutively incubated in the presence of
the corresponding horseradish peroxidase (HRP)-conjugated secondary antibody. Band detec-
tion was performed with enhanced chemiluminescent substrate and visualized using lumines-
cent image analyzer LAS-3000 (Fujifilm, Dielsdorf, Switzerland). Blot quantification was
performed using ImageJ software (ImageJ, NIH, Maryland, USA). For protein detection with
Western blotting, antibodies against ZO-1 were provided by Life technologies, for histone 3 by
Cell Signaling (CST, Leiden, Netherlands), while secondary (HRP-coupled) antibodies were
provided by Sigma and β-catenin antibodies by BD (Biosciences, Allschwil, Switzerland). The
Sevoflurane postconditioning of injured brain endothelial cells
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protein amount was normalized to the mean protein expression in normoxia and adjusted for
the histone 3 loading control.
Immunofluorescence
Cells were grown on poly-D-lysine hydrobromide (50–100μg (cm2)-1 Sigma) and collagen-
coated glass cover slips (Karl Hecht GmbH&Co KG, Sondheim, Germany) and exposed to
normoxia or severe hypoxia prior to 4h reoxygenation with or without sevoflurane as
described. The monoclonal mouse anti-β-catenin antibody was used at a dilution of 1:500
(BD), monoclonal mouse anti-ZO-1 antibody at a dilution of 1:100 and phalloidin-Alexa 568
at 1:30 (both Life Technologies). The secondary anti-mouse Alexa-Fluor 488 antibody (Life
technologies) was applied at a dilution of 1:500 and 4’, 6-diamidino-2-phenylindole (DAPI,
Roche Diagnostics, Mannheim, Germany) for nuclear staining was diluted to 1:1000.
Microscopy
Bright field pictures of RBE4 monolayers were taken with an inverted widefield fluorescence
microscope (Leica DMI 6000, Leica Microsystems, Heerbrugg, Switzerland) and a cooled fluo-
rescence monochrome camera (Leica DFC 350 FX, 1392 x 1040 pixel, pixel size 6.4 μm.
DNA quantification assay
In order to detect changes in DNA content, a quantification assay was performed using Bis-
benzimide Hoechst 33342 (Sigma). Fluorescence was measured with a fluorometer (Tecan) at
ex/em 360/460nm.
LDH release assay
For quantification of lactate dehydrogenase (LDH) release, the CytoTox1Non-Radioactive
Cytotoxicity Assay (Promega, Du¨bendorf, Switzerland) was used. With the aid of this enzy-
matic assay, LDH, a cytosolic enzyme is measured in cell culture supernatants at an absorbance
of 492nm with a spectrometer (Tecan). For maximum lysis control, lysis buffer was added 4
hours prior to detection.
Caspase assay
In order to quantify the cellular caspase activity, we used a selective caspase substrate for the
caspases 3, 7 and 8 coupled to a fluorescent dye (Ac-Asp-Glu-Val-Asp-AMC; 3171v, Pepta-
nova, Sandhausen, Germany). When the caspases are present, the fluorogenic AMC residue is
cleaved and can be detected at ex/em 360/ 465nm with a fluorometer (Tecan).
Flow cytometry and cell size measurement
For flow and imaging cytometry cells were washed twice with 2.5mmol EDTA in PBS,
detached with trypsin-EDTA solution (0.05%) (Thermo, Reinach, Switzerland) and put
through a 35μm cell strainer (Falcon, Corning, USA) after resuspension. The fixable viability
dye eFluor1 660 (e Bioscience, Hatfield, UK) was used for viability analysis in accordance
with the manufacturer’s instructions. For cell analysis, BD FACS Canto II (BD) and Image
Stream X Mark II (Merck, Millipore, Schaffhausen, Switzerland) were used. Doublets were
excluded with the aid of a pulse geometry gate (FS-H x FS-A) in the flow cytometer and micro-
scopically in the Image Stream analysis. Dead cells were excluded upon staining. For the flow
cytometry analysis, the FSC-A voltage values of the first 500 cells in each experiment were ana-
lyzed and normalized to normoxia. For image stream analysis, cell size for every measured cell
Sevoflurane postconditioning of injured brain endothelial cells
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was determined. ANOVA and Bonferroni correction was used for comparison of the different
conditions.
VEGF analysis using enzyme linked immunoabsorbant assays
ELISA kits for VEGF were obtained from R&D Systems Europe (Abingdon, UK). Assays were
performed according to the manufacturer´s instructions. Cells were grown on collagen-coated
plates at a density of 50,000 ml-1 for 2 days and exposed to severe hypoxia (24 hours) and reox-
ygenation (4 hours) with or without sevoflurane as described above. Afterwards, cell superna-
tants were collected and VEGF protein content quantified.
Addition of VEGF antibody and recombinant VEGF during the
reoxygenation period
In order to assess the effect of VEGF during the reoxygenation period, permeability experi-
ments were performed as described above. During the 4-hour reoxygenation period, VEGF
antibody (AF564 goat anti-rat VEGF antibody, R&D, Abingdon, UK) was added at a concen-
tration of 1μg/ml, the corresponding goat IgG served as a control as previously described [22].
In order to assess whether the effect of sevoflurane can be reversed by recombinant VEGF
(rVEGF), VEGF protein was added at a concentration of 50ng/ml [23].
Data analysis, statistics and graphs
Data are graphed with mean values with standard deviation represented as whiskers. Each
assay was performed at least three times independently. Statistical analysis was performed
using either paired, two tailed-t-tests for two groups or one way-analysis of variance
(ANOVA) for more than two groups, with Bonferroni’s correction for multiple comparisons.
Flow cytometry data was analyzed using FACS DIVA 8.0.1 and FlowJo software. Image stream
data were processed using Image Data Exploration and Analysis software (IDEAS) (Amnis,
Seattle, WA, USA). Densitometry analysis and areas of phalloidin staining were assessed with
the aid of image J. To identify actin tangles, a threshold of 37 was set and pixels above 37 were
defined as actin positive. Below this cut-off, actin was not clearly positive. The number of actin
positive pixels per image was then counted on binary images (representing total phalloidin of the
entire cells). For subcellular analysis, the program “CellProfiler” (www.cellprofiler.org) [24] was
used to identify the nuclei (pixel range between 35–120 pixel units) in each image as primary
objects. In a next step, the cell cytoplasm was identified as secondary object characterized by the
area surrounding the nucleus limited by continuous F-actin tangles at the cell border. Identifica-
tion of the secondary objects was performed with the aid of the watershed tool. Then, the inte-
grated F-actin staining intensity was evaluated for each cell. Data was analyzed and graphs
created using Graph Pad Prism 6 (San Diego, CA, USA) and IBM1 SPSS statistics 22.0.0.0.
Results
The complete data set for the manuscript can be found in supplementary online content S2
Table. All relevant data are within the paper and its Supporting Information files.
Sevoflurane postconditioning improves barrier function in rat brain
endothelial cells exposed to H/R
When plotting the FITC-clearance against time, the curves showed a linear relationship. H/R
injury induced an increase in cleared volume over time, while sevoflurane postconditioning
reduced it (Fig 1A). The corresponding Pe values in normoxia were 6±1.5 x10-3cm/min. After
Sevoflurane postconditioning of injured brain endothelial cells
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30 minutes, a 172% increase of permeability of the RBE4 monolayer was observed (normoxia:
100±31%, H/R+air: 272±135%, p<0.001). With the addition of sevoflurane during the reoxy-
genation period, barrier function significantly improved, leading to a 96% decrease in perme-
ability (p<0.05; Fig 1B).
Sevoflurane postconditioning preserves cellular arrangement of junction
proteins in rat brain endothelial cells in H/R injury
Alteration of tight and adherens junction components, namely ZO-1 and β-catenin in RBE4
cells, were assessed in response to H/R+air as illustrated in Fig 2A and Fig 2B. Under H/R+air
tight and adherens junction proteins in the larger cells appear disrupted with better main-
tained morphology in the presence of sevoflurane. For further quantification, Western blot
analysis was performed and showed no alteration in the total amount of ZO-1 or β-catenin
Fig 1. Sevoflurane and barrier function in rat brain endothelial cells in H/R injury. RBE4 cells were
exposed to severe hypoxia (0.2% oxygen) for 24 hours, followed by a 4-hour period of reoxygenation in air (H/
R+air) or air enriched with sevoflurane (H/R+sevo). Cells in the normoxia group remained in a normal cell
culture environment with 21% oxygen for the full 28 hours. Clearance and permeability were determined using
FITC-dextran. FITC clearance was measured after 10, 20 and 30 minutes (A). Permeability was assessed
after 30 minutes and normoxia was defined as 100% (B). Bar graphs show mean values and standard
deviations. n = 11 in each group, analyzed with ANOVA and Bonferroni correction. *** p<0.001, * p< 0.05.
https://doi.org/10.1371/journal.pone.0184973.g001
Sevoflurane postconditioning of injured brain endothelial cells
PLOS ONE | https://doi.org/10.1371/journal.pone.0184973 October 12, 2017 6 / 17
(Fig 2C). However, cell size increased under H/R+air, while sevoflurane partially mitigated
this swelling (Fig 2A).
Fig 2. Sevoflurane and architecture of intercellular junction proteins of rat brain endothelial cells in H/R injury. RBE4
cells were exposed to severe hypoxia (0.2% oxygen) for 24 hours, followed by a 4-hour period of reoxygenation in air (H/R+air) or
air enriched with sevoflurane (H/R+sevo). Cells in the normoxia group remained in a normal cell culture environment with 21%
oxygen for the full 28 hours. After fixation, the junctional molecules ZO-1 (A) and β-catenin (B) were stained using according
antibodies as shown in green, and the nucleus was visualized with DAPI as demonstrated in blue. Western blots were performed
with according antibodies against ZO-1 and β-catenin with histone 3 as control (C). Bar graphs show mean values and standard
deviations. n = 4 separate stainings for each group and antibody, ZO-1 and β-catenin protein analysis n = 6 per group, analyzed
with ANOVA and Bonferroni correction.
https://doi.org/10.1371/journal.pone.0184973.g002
Sevoflurane postconditioning of injured brain endothelial cells
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Sevoflurane does not improve H/R-induced decrease of DNA content,
increase of LDH and enhanced caspase activity
In a further step, it was determined whether changes in permeability and tight junction organi-
zation were associated with a reduced cell number and/or an increased necrosis or apoptosis
rate. Compared to cells incubated under normoxic conditions, H/R decreased the DNA con-
tent by 20% (normoxia 100±3% H/R+air 81±2%, p<0.001) (Fig 3A), increased LDH release by
4% (normoxia 21±4%, H/R+air 25%±4%, p<0.01) (Fig 3B) and increased caspase activity by
71% (normoxia 100±21%, H/R+air 171±67%, p<0.001) (Fig 3C). However, addition of 2.2%
sevoflurane during the reoxygenation period did not have an impact on these three parameters
(Fig 3).
Sevoflurane postconditioning preserves cell size in H/R injury
To verify observed changes of cell size in Fig 2 further experiments were performed using flow
cytometry and image stream. H/R induced a mean forward scatter area (FSC-A) increase by
8.6% (p<0.001), while sevoflurane treatment decreased this change to 3.5% (p<0.001) (Fig
4A). This FSC-A-change correlated well with cell size changes in image stream analysis, which
revealed a mean area of 237μm2 for cells grown in normoxia, a cell size increase after H/R,
which was more pronounced when cells were reoxygenated with air (average area 250μm2)
compared to reoxygenation with sevoflurane (average area 242μm2). These changes were sig-
nificant for each experiment (p<0.001 for normoxia vs. H/R + air and p<0.001 for H/R + air
vs. H/R + sevo) (Fig 4B).
Sevoflurane acts on F-actin cytoskeleton
In order to know whether the volume changes translate into changes of the cytoskeleton phal-
loidin stainings were performed. RBE4 cells grown in normoxia showed predominantly mem-
brane associated F-actin, while after H/R the normal F-actin structure was disrupted. In the
presence of sevoflurane during reoxygenation F-actin was associated in bundles and redirected
to the cell membrane (Fig 5A and Fig 5B). While this qualitative difference was observed, total
F-actin did not differ (Fig 5C). Segmentation of each cell into cytoplasm and nucleus revealed
an increase of F-actin in response to H/R+air both in the cytoplasm and in the nuclei com-
pared to H/R+sevo (Fig 5D and Fig 5E), with F-actin primarily localized at the cell membrane.
Detailed evaluation revealed that the amount of F-actin within the cell cytoplasm increased by
55% (p<0.001) when exposed to H/R+air. Reoxygenation in the presence of sevoflurane (H/R
+sevo) attenuated this by 22% compared to H/R+air (p<0.005) (Fig 5D). Additionally, after
H/R+air, more F-actin tangles were observed in the nucleus area compared to the normoxic
condition (22% increase, p< 0.001). The reduction of integrated intensity in the nuclear area
after sevoflurane postconditioning was 48% (p<0.001) (Fig 5E).
Sevoflurane postconditioning attenuates increased VEGF levels after H/
R injury
VEGF protein concentration was measured in the RBE4 cell supernatant. This mediator
VEGF was hardly detectable in normoxia at 167±82pg ml-1 (Fig 6A). However, the concentra-
tion significantly increased in response to H/R+air to 2597pg ml-1 (±888pg ml-1, p<0.001),
while sevoflurane exposure reduced VEGF levels by 878pg ml-1 (p<0.01). In order to know
whether the changes in permeability might be mediated by VEGF, this inflammatory mediator
was blocked and the increase in permeability was mitigated (H/R+air 237±90% vs. H/R
+VEGF antibody 118± 42% (p = 0.001) compared to the normoxic control (Fig 6B). Addition
Sevoflurane postconditioning of injured brain endothelial cells
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Fig 3. Sevoflurane and DNA content, LDH release and caspase activity in rat brain endothelial cells in
H/R injury. RBE4 cells were exposed to severe hypoxia (0.2% oxygen) for 24 hours, followed by a 4-hour
period of reoxygenation in air (H/R+air) or air enriched with sevoflurane (H/R+sevo). Cells in the normoxia
group remained in a normal cell culture environment with 21% oxygen for the full 28 hours. Determination of
DNA was performed using fluorogenic bisbenzimide (A). LDH release was measured with the aid of a non-
radioactive cytotoxicity assay (B). Caspase 3/7/8 activity was assessed with a cleavage assay (C). Bar
graphs show mean values and standard deviations. n = 18 for each group (DNA content), n = 24 for each
group (LDH release and caspase activity), analyzed with ANOVA and Bonferroni correction. ** p<0.01, ***
p< 0.001.
https://doi.org/10.1371/journal.pone.0184973.g003
Sevoflurane postconditioning of injured brain endothelial cells
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of rVEGF during reoxygenation abolished the sevoflurane-mediated beneficial effect on per-
meability (Fig 6C).
Discussion
Blood-brain barrier disruption is highly relevant in the pathogenesis of secondary brain dam-
age after brain injury [12, 25]. In the present study, we show for the first time that sevoflurane
treatment during the early reoxygenation period following severe hypoxia promotes the main-
tenance of BBB structure and function in rat brain endothelial cells. The permeability patterns
of the RBE4 grown on Transwells™ were comparable with the data shown by Rist et al. [21]
with Pe-values of 6x10
-3cm per minute in normoxia.
The increased permeability for macromolecular FITC dextran after H/R reflects a severe
barrier disruption in RBE4 monolayers, consistent with previously published data [26]. These
Fig 4. Sevoflurane and rat brain endothelial cell size in H/R injury. RBE4 cells were exposed to severe
hypoxia (0.2% oxygen) for 24 hours, followed by a 4-hour period of reoxygenation in air (H/R+air) or air
enriched with sevoflurane (H/R+sevo). Cells in the normoxia group remained in a normal cell culture
environment with 21% oxygen for the full 28 hours. After detachment with trypsin-EDTA and viability staining,
cells were analyzed with the flow cytometer or image stream, respectively. FSC-A as an indirect measure of
cell size was assessed in conventional flow cytometry (A), while the cell size of each cell was assessed with
the image stream method (B). The histogram shows the distribution pattern of FSC-A seen in the flow
cytometry. n = 5 independent experiments, with 500 cells analyzed in each condition. The bar graph shows
mean values and standard deviations. n = 4 Image stream X experiments, at least 20,000 cells analyzed in
each condition. Analysis with one way ANOVA and Bonferroni correction. *** p<0.001.
https://doi.org/10.1371/journal.pone.0184973.g004
Sevoflurane postconditioning of injured brain endothelial cells
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changes can be explained by dysregulated tight and adherens junction proteins [27], which
normally limit the paracellular flux [28] and orchestrate intercellular contact formation [29].
ZO-1-depleted cells lack functional junctions [29], and endothelial cells with conditional inac-
tivation of β-catenin exhibit reduced cell adhesion and increased permeability [30]. Interest-
ingly, in our experiments, the amount of tight and adherens junction proteins tested was not
reduced after H/R, suggesting that application of sevoflurane helps to reorganize the existing
protein structures without any quantitative change. Although beyond the scope of our experi-
ments, it is tempting to further assess if severe hypoxia alone modifies junctional integrity and
to which extend the reoxygenation process changes these dynamics.
We showed that H/R injury in brain endothelial cells induces both necrosis as reflected by
decreased DNA content and increased LDH release as well as apoptosis, which was defined by
increased caspase activity. One would expect an improved barrier function in the presence of
sevoflurane lowering death rate. However, the application of sevoflurane did not impact on
necrosis or on apoptosis. Sevoflurane rather influenced cell size and structural organization of
the endothelial cells and thereby counteracted impaired barrier function.
Swelling of the endothelial cells due to edema formation is described as a prominent feature
after H/R [31], and may indeed lead to disruption of the junctions. It is quantified by both flow
cytometry and image stream. While the voltage of the forward scatter in flow cytometry analy-
sis can both be modified by cell size and the refractive index differences of fluids and cells [32],
microscopical analysis via image stream can accurately determine the cell size [33]. When
comparing the images of cells either reoxygenated with air or with sevoflurane, computational
analysis identified the cell size as differentiating factor between the treatment groups.
One of the most potent vascular permeability factors is VEGF [6]. In our experimental set-
ting, this signaling molecule was significantly upregulated in response to H/R. At the same
time, sevoflurane reduced VEGF expression relative to H/R without sevoflurane postcondi-
tioning. VEGF increases nuclear levels of β-catenin and modifies its subcellular distribution
without changing the total cell amount of this adherens junction protein [34]. Besides this
direct action on tight and adherens junction proteins [34, 35]. VEGF may also have an indirect
effect on cell size [36]. In vivo it has been shown that an early blockade of VEGF reduces brain
tissue edema formation in mice after stroke [37] and that it also attenuates on a cellular level
the extent of cell swelling induced by cytotoxic edema after cerebral venous infarction in rats
[38]. In our experiments, we could demonstrate on a cellular level, that H/R induces cell swell-
ing, which is mitigated by sevoflurane treatment, possibly via downregulation of VEGF.
It is important to realize that F-actin structure and regulation [39], which is supposed to be
involved in the spatial control and stabilization of cellular junctions [40], may be another com-
ponent being influenced in the presence of sevoflurane. H/R injury caused disruption of F-
actin, sevoflurane, however, stabilized arrangement of F-actin.
Fig 5. Sevoflurane and rat brain endothelial cell organization of actin cytoskeleton after H/R injury.
RBE4 cells were exposed to severe hypoxia (0.2% oxygen) for 24 hours, followed by a 4-hour period of
reoxygenation in air (H/R+air) or air enriched with sevoflurane (H/R+sevo). Cells in the normoxia group
remained in a normal cell culture environment with 21% oxygen for the full 28 hours. Phalloidin staining
visualizes F-actin tangles as seen in red, blue DAPI staining shows cell nuclei (A). Quantitative assessment of
F-actin was performed by determination of F-actin pixels per image above the threshold of 37 in Image J (A, C).
To further evaluate morphological changes, segmentation was performed targeting the cytoplasm surrounded
with green lines and the nucleus surrounded with a cyan line (B). The integrated intensity in these regions of
interest was then analyzed (cytoplasm, D) and (nucleus, E). n = 3 independent experiments with 3 analyzed
images per condition per experiment. Analysis of the mean of each experiment with one way ANOVA and
Bonferroni correction.
https://doi.org/10.1371/journal.pone.0184973.g005
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Fig 6. Sevoflurane and the role of VEGF expressed by rat brain endothelial cell in H/R. RBE4 cells were
exposed to severe hypoxia (0.2% oxygen) for 24 hours, followed by a 4-hour reoxygenation period in air (H/R
+air) or air enriched with sevoflurane (H/R+sevo). Cells in the normoxia group remained in a normal cell culture
environment with 21% oxygen for the full 28 hours. VEGF protein was determined in the supernatant using
ELISA (A). RBE4 cells were exposed to hypoxia (0.2% oxygen) for 24 hours, followed by a 4-hour reoxygenation
period in air (H/R+air) or air enriched with a VEGF antibody (1μg/ml). As a control iso IgG was used. Permeability
was assessed at 30 minutes using FITC-dextran. Normoxia was defined as 100% (B). RBE4 cells were exposed
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While an established and elegant model [19], our in vitro approach has its limitations. The
effects detected are specific for endothelial cells and cannot reflect the full complexity of the
cellular interplay at the BBB including astrocytes and pericytes. Moreover, every immortalized
cell line is modified to allow cell processing and tissue specific functions may not be fully rep-
resented [41]. Finally, although we detected that sevoflurane reduces VEGF protein secretion,
which is potentially involved in junctional and cellular changes, we did not elucidate the
detailed signaling pathway.
In summary, we show that the impairment of barrier function in brain endothelial cells is
improved by sevoflurane postconditioning. This anesthetic acts on tight and adherens junc-
tions, possibly through the attenuation of injury-induced production of VEGF. This signaling
pathway may be an interesting future drug target, but needs to be further assessed in detail in
in vivo studies.
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